Zobrazeno 1 - 10
of 1 941
pro vyhledávání: '"Gerritsen WR"'
Autor:
Trump, Donald L.
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations November 2013 31(8):1846-1846
Autor:
Trump D
Publikováno v:
Urologic oncology [Urol Oncol] 2016 May; Vol. 34 (5), pp. 249-50. Date of Electronic Publication: 2015 Apr 20.
Autor:
Donald Trump
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 34:249-250
Autor:
van Wilpe S; Department of Medical Oncology., Kloots ISH; Department of Medical Oncology., Slootbeek PHJ; Department of Medical Oncology., den Brok M; Department of Medical Oncology., Westdorp H; Department of Medical Oncology., Franken MD; Department of Medical Oncology., Coskunturk M; Department of Medical Oncology., Osinga T; Department of Medical Oncology., Bloemendal H; Department of Medical Oncology., Adema G; Department of Radiation Oncology., Smeenk RJ; Department of Radiation Oncology., Nagarajah J; Department of Medical Imaging., van Ipenburg J; Department of Pathology., Kroeze LI; Department of Pathology., Ligtenberg MJL; Department of Pathology; Department of Human Genetics., Schalken J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology., Mehra N; Department of Medical Oncology. Electronic address: Niven.mehra@radboudumc.nl.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.dewit@erasmusmc.nl., Vaughn DJ; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Fradet Y; Department of Surgery/Urology, CHU de Québec-Université Laval Research Center, Quebec, QC, Canada., Fong L; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Climent MA; Department of Medical Oncology, Valencian Institute of Oncology (IVO Foundation), Valencia, Spain., Necchi A; Department of Medical Oncology, Vita-Salute San Raffaele University and IRCCS Ospedale San Raffaele, Milan, Italy., Petrylak DP; Department of Internal Medicine/Medical Oncology, Smilow Cancer Hospital, Yale New Haven Health, New Haven, CT, USA., Gerritsen WR; Department of Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gurney H; Department of Medical Oncology, Westmead Hospital and Macquarie University, Sydney, NSW, Australia., Quinn DI; Developmental Therapeutics Program, USC Norris Comprehensive Cancer Center and Division of Cancer Medicine and Blood Diseases, Keck Medicine of USC, Los Angeles, CA, USA., Culine S; Department of Medical Oncology, Saint-Louis Hospital, Paris, France., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Meyer Cancer Center, New York-Presbyterian, New York, NY, USA., Bajorin DF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Choueiri TK; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Xu J; Department of Medical Oncology, Merck & Co. Inc, Rahway, NJ, USA., Imai K; Department of Medical Oncology, Merck & Co. Inc, Rahway, NJ, USA., Homet Moreno B; Department of Medical Oncology, Merck & Co. Inc, Rahway, NJ, USA., Bellmunt J; Department of Medical Oncology, Dana-Farber Cancer Institute and IMIM Research Institute, Harvard Medical School, Boston, MA, USA., Lee JL; Division of Oncology, Department of Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea.
Publikováno v:
European urology [Eur Urol] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.
Autor:
Graff JN; Oregon Health and Science University, Portland, OR, USA. graffj@ohsu.edu., Hoimes CJ; Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.; Duke University School of Medicine, Durham, NC, USA., Gerritsen WR; Radboud University Medical Center, Nijmegen, Netherlands., Vaishampayan UN; University of Michigan and Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Elliott T; NHS Lothian, Edinburgh, UK., Hwang C; Henry Ford Health System, Detroit, MI, USA., Ten Tije AJ; Amphia Hospital, Breda, Netherlands., Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland., McDermott RS; Tallaght University Hospital, Dublin, Ireland., Fradet Y; CHU de Québec-Université Laval, Québec City, QC, Canada., Tagawa ST; Weill Cornell Medical College, New York, NY, USA., Kilari D; Medical College of Wisconsin, Milwaukee, WI, USA., Ferrario C; Jewish General Hospital, Montreal, QC, Canada., Uemura H; Yokohama City University Medical Center, Yokohama, Japan., Jones RJ; University of Glasgow, Glasgow, UK., Fukasawa S; Chiba Cancer Center, Chiba, Japan., Peer A; Rambam Health Care Campus, Haifa, Israel., Niu C; MSD China, Beijing, China., Poehlein CH; Merck & Co., Inc., Rahway, NJ, USA., Qiu P; Merck & Co., Inc., Rahway, NJ, USA., Suttner L; Merck & Co., Inc., Rahway, NJ, USA., de Wit R; Erasmus University Medical Center, Rotterdam, Netherlands., Schloss C; Merck & Co., Inc., Rahway, NJ, USA., de Bono JS; The Royal Marsden Hospital NHS Foundation Trust and the Institute of Cancer Research, London, UK., Antonarakis ES; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.; University of Minnesota, Masonic Cancer Center, Minneapolis, MN, USA.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12.
Autor:
Donald L. Trump
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 31:1846
Autor:
van der Doelen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Maarten.vanderDoelen@radboudumc.nl.; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Maarten.vanderDoelen@radboudumc.nl., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands., Wyndaele DNJ; Department of Nuclear Medicine, Catharina Hospital, Eindhoven, The Netherlands., van Basten JP; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Terheggen F; Department of Medical Oncology, Bravis Hospital, Roosendaal, The Netherlands., van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de Graaf Gasthuis and Reinier Haga Prostate Cancer Center, Delft, The Netherlands., Oyen WJG; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy., van Schelven WD; Department of Nuclear Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., van den Berkmortel F; Department of Medical Oncology, Zuyderland Medical Center, Sittard, The Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Janssen MJR; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Prins JB; Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Custers JAE; Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Mar; Vol. 26 (1), pp. 142-150. Date of Electronic Publication: 2022 Jul 08.
Autor:
Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van Wilpe S; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Geerlings MJ; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., von Rhein D; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., Kloots ISH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Westdorp H; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Coskuntürk M; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands., van Ipenburg JA; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Hofste T; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Weiss MM; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Schalken JA; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Niven.mehra@radboudumc.nl.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Apr; Vol. 7 (2), pp. 282-291. Date of Electronic Publication: 2023 Sep 04.
Autor:
Bosch D; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Velden KJM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands., Wyndaele DNJ; Department of Nuclear Medicine, Catharina Hospital, Eindhoven, The Netherlands., Weijs LE; Department of Radiology and Nuclear Medicine, Ziekenhuisgroep Twente, Almelo, Netherlands., van Schelven WD; Department of Nuclear Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Oyen WJG; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy., Te Beek ET; Department of Nuclear Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands., van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de G raaf Gasthuis and Reinier Haga Prostate Cancer Center, Delft, The Netherlands., Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Hermsen R; Department of Nuclear Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands; and., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Doelen MJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; maarten.vanderdoelen@radboudumc.nl., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Apr 01; Vol. 65 (4), pp. 541-547. Date of Electronic Publication: 2024 Apr 01.